Brain-relevant antibodies in first-episode psychosis: a matched case-control study.

Citation data:

Psychological medicine, ISSN: 1469-8978, Vol: 48, Issue: 8, Page: 1257-1263

Publication Year:
2018
Usage 22
Downloads 14
Abstract Views 8
Captures 24
Readers 24
Social Media 3
Tweets 3
Citations 1
Citation Indexes 1
Repository URL:
https://epubs.rcsi.ie/psychart/72
PMID:
28920570
DOI:
10.1017/s0033291717002689
Author(s):
Gaughran, Fiona; Lally, John; Beck, Katherine; McCormack, Ruaidhri; Gardner-Sood, Poonam; Coutinho, Ester; Jacobson, Leslie; Lang, Bethan; Sainz-Fuertes, Ricardo; Papanastasiou, Evangelos; Di Forti, Marta; Nicholson, Tim; Vincent, Angela; Murray, Robin M Show More Hide
Publisher(s):
Cambridge University Press (CUP); Cambridge University Press
Tags:
Psychology; Medicine; Antibodies; FEP; NMDA; VGKC-complex; first-episode psychosis; schizophrenia.; Medicine and Health Sciences; Psychiatry and Psychology
Most Recent Tweet View All Tweets
article description
There has been much recent excitement about the possibility that some cases of psychosis may be wholly due to brain-reactive antibodies, with antibodies to N-methyl-D-aspartate receptor (NMDAR) and the voltage-gated potassium channel (VGKC)-complex reported in a few patients with first-episode psychosis (FEP).